Drug intelligence / Profile preview

Pouxit

Development stage
Unknown
Lead developer
Cooper Laboratories
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Pouxit is an over-the-counter (OTC) anti-lice treatment line developed and marketed by Coopération Pharmaceutique Française (Cooper). Launched in 2006, the product line is indicated for the treatment of head lice (*Pediculus humanus capitis*) and nits in adults and children over 6 months of age. Unlike traditional pediculicides that rely on neurotoxic insecticides, Pouxit utilizes a physical mechanism of action, primarily employing dimethicone to coat and suffocate the parasites and their eggs. This non-chemical approach prevents the development of resistance and is gentler on the scalp. The brand offers several specialized formulations, including Pouxit Flash, which acts in 5 minutes, and Pouxit XF (Extra Fort), which is designed for enhanced efficacy. In many European jurisdictions, including France, Pouxit products are regulated as medical devices.

Brand names
PouxitPouxit FlashPouxit XFPouxit Extra FortPouxit Végétal

Beyond the preview

Go deeper on Pouxit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pouxit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call